Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.28%4.72B | 0.54%4.63B | 9.91%19.06B | 4.58%4.75B | 17.04%4.99B | 8.91%4.71B | 9.48%4.61B | -2.81%17.34B | 1.72%4.55B | -6.98%4.27B |
| Operating revenue | 0.28%4.72B | 0.54%4.63B | 9.91%19.06B | 4.58%4.75B | 17.04%4.99B | 8.91%4.71B | 9.48%4.61B | -2.81%17.34B | 1.72%4.55B | -6.98%4.27B |
| Cost of revenue | -3.06%3.2B | -1.38%3.15B | 12.18%13.37B | 4.40%3.27B | 20.14%3.56B | 12.44%3.3B | 10.77%3.2B | -4.06%11.91B | 1.69%3.13B | -6.00%2.96B |
| Gross profit | 8.09%1.52B | 4.90%1.48B | 4.94%5.7B | 4.96%1.48B | 10.02%1.44B | 1.44%1.41B | 6.67%1.41B | 0.06%5.43B | 1.80%1.41B | -9.11%1.31B |
| Operating expense | 3.88%1.23B | 2.29%1.21B | 4.52%4.78B | 3.50%1.27B | 6.93%1.19B | 4.59%1.19B | 6.89%1.18B | 3.06%4.58B | 8.58%1.23B | -1.86%1.11B |
| Selling and administrative expenses | 4.17%1.08B | 2.13%1.05B | 4.35%4.15B | 3.08%1.1B | 6.54%1.03B | 4.45%1.03B | 7.73%1.03B | 3.19%3.98B | 8.51%1.07B | -2.13%964M |
| -Selling and marketing expense | -2.87%169M | -3.21%181M | 1.67%731M | -3.19%182M | 5.75%184M | -2.79%174M | 5.06%187M | -11.67%719M | -7.84%188M | -17.54%174M |
| -General and administrative expense | 5.59%906M | 3.32%872M | 4.94%3.42B | 4.42%922M | 6.71%843M | 6.06%858M | 8.34%844M | 7.16%3.26B | 12.77%883M | 2.07%790M |
| Depreciation amortization depletion | 1.96%156M | 3.38%153M | 5.71%629M | 6.37%167M | 9.52%161M | 5.52%153M | 1.37%148M | 2.23%595M | 9.03%157M | 0.00%147M |
| -Depreciation and amortization | 1.96%156M | 3.38%153M | 5.71%629M | 6.37%167M | 9.52%161M | 5.52%153M | 1.37%148M | 2.23%595M | 9.03%157M | 0.00%147M |
| Operating profit | 30.22%293M | 18.34%271M | 7.15%914M | 14.75%210M | 27.55%250M | -12.45%225M | 5.53%229M | -13.49%853M | -28.24%183M | -35.95%196M |
| Net non-operating interest income (expenses) | 16.33%-41M | -21.05%-46M | -11.36%-196M | -14.00%-57M | -23.81%-52M | -11.36%-49M | 5.00%-38M | -21.38%-176M | -28.21%-50M | -13.51%-42M |
| Non-operating interest income | ---- | ---- | ---- | ---- | --0 | ---- | --0 | -60.00%2M | --0 | 0.00%1M |
| Non-operating interest expense | -9.68%28M | -9.68%28M | 0.00%120M | -10.00%27M | 0.00%31M | 3.33%31M | 6.90%31M | 20.00%120M | 3.45%30M | 24.00%31M |
| Total other finance cost | -27.78%13M | 157.14%18M | 31.03%76M | 50.00%30M | 75.00%21M | 28.57%18M | -41.67%7M | 16.00%58M | 66.67%20M | -7.69%12M |
| Other net income (expenses) | 128.57%2M | 25.00%-3M | -169.96%-737M | -278.57%-53M | -172.47%-673M | 46.15%-7M | -500.00%-4M | -313.64%-273M | 60.00%-14M | -436.96%-247M |
| Gain on sale of security | -90.91%1M | -66.67%2M | -63.93%22M | -102.56%-1M | -77.78%6M | 375.00%11M | 700.00%6M | 506.67%61M | 657.14%39M | 437.50%27M |
| Special income (charges) | 105.56%1M | 50.00%-5M | -127.25%-759M | 1.89%-52M | -147.81%-679M | -100.00%-18M | -600.00%-10M | -554.90%-334M | -89.29%-53M | -621.05%-274M |
| -Less:Restructuring and mergern&acquisition | --0 | --6M | 248.00%87M | 321.05%80M | --0 | --7M | --0 | -73.68%25M | -32.14%19M | -84.21%6M |
| -Less:Impairment of capital assets | ---- | ---- | 158.11%684M | --0 | 158.11%684M | ---- | ---- | --265M | --0 | --265M |
| -Less:Other special charges | -109.09%-1M | -110.00%-1M | -72.73%12M | -111.76%-4M | -266.67%-5M | 22.22%11M | 600.00%10M | 200.00%44M | --34M | --3M |
| -Gain on sale of property,plant,equipment | ---- | ---- | --24M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Income before tax | 50.30%254M | 18.72%222M | -104.70%-19M | -15.97%100M | -410.75%-475M | -15.50%169M | 5.06%187M | -47.87%404M | -34.25%119M | -141.70%-93M |
| Income tax | 60.47%69M | 26.67%57M | 12.95%157M | -3.70%26M | 38.71%43M | -2.27%43M | 21.62%45M | -9.15%139M | 22.73%27M | -29.55%31M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 46.83%185M | 16.20%165M | -166.42%-176M | -19.57%74M | -317.74%-518M | -19.23%126M | 0.71%142M | -57.40%265M | -42.14%92M | -169.27%-124M |
| Net income continuous operations | 46.83%185M | 16.20%165M | -166.42%-176M | -19.57%74M | -317.74%-518M | -19.23%126M | 0.71%142M | -57.40%265M | -42.14%92M | -169.27%-124M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 46.83%185M | 16.20%165M | -166.42%-176M | -19.57%74M | -317.74%-518M | -19.23%126M | 0.71%142M | -57.40%265M | -42.14%92M | -169.27%-124M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 46.83%185M | 16.20%165M | -166.42%-176M | -19.57%74M | -317.74%-518M | -19.23%126M | 0.71%142M | -57.40%265M | -42.14%92M | -169.27%-124M |
| Diluted earnings per share | 50.00%0.45 | 21.21%0.4 | -165.08%-0.41 | -18.18%0.18 | -320.69%-1.22 | -18.92%0.3 | 0.00%0.33 | -57.72%0.63 | -42.11%0.22 | -167.44%-0.29 |
| Basic earnings per share | 50.00%0.45 | 21.21%0.4 | -165.08%-0.41 | -18.18%0.18 | -320.69%-1.22 | -18.92%0.3 | 0.00%0.33 | -57.43%0.63 | -40.54%0.22 | -167.44%-0.29 |
| Dividend per share | 5.26%0.2 | 2.70%0.19 | 2.72%0.755 | 2.70%0.19 | 2.70%0.19 | 2.70%0.19 | 2.78%0.185 | 2.08%0.735 | 2.78%0.185 | 2.78%0.185 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.